MXPA01001090A - Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos. - Google Patents

Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos.

Info

Publication number
MXPA01001090A
MXPA01001090A MXPA01001090A MXPA01001090A MXPA01001090A MX PA01001090 A MXPA01001090 A MX PA01001090A MX PA01001090 A MXPA01001090 A MX PA01001090A MX PA01001090 A MXPA01001090 A MX PA01001090A MX PA01001090 A MXPA01001090 A MX PA01001090A
Authority
MX
Mexico
Prior art keywords
polypeptide
polynucleotide
chlamydia
antibody
sequence
Prior art date
Application number
MXPA01001090A
Other languages
English (en)
Spanish (es)
Inventor
Andrew D Murdin
Original Assignee
Connaught Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Connaught Lab filed Critical Connaught Lab
Publication of MXPA01001090A publication Critical patent/MXPA01001090A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56927—Chlamydia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
MXPA01001090A 1998-07-27 1999-07-27 Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos. MXPA01001090A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US9420398P 1998-07-27 1998-07-27
US12204599P 1999-03-01 1999-03-01
US36043499A 1999-07-26 1999-07-26
PCT/IB1999/001333 WO2000006743A2 (fr) 1998-07-27 1999-07-27 Antigenes de chlamydia et fragments d'adn correspondants, et utilisations de ceux-ci

Publications (1)

Publication Number Publication Date
MXPA01001090A true MXPA01001090A (es) 2002-06-04

Family

ID=27377706

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01001090A MXPA01001090A (es) 1998-07-27 1999-07-27 Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos.

Country Status (6)

Country Link
EP (1) EP1108033A2 (fr)
JP (1) JP2002524035A (fr)
AU (1) AU4793499A (fr)
CA (1) CA2336534A1 (fr)
MX (1) MXPA01001090A (fr)
WO (1) WO2000006743A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU772356B2 (en) * 1998-12-04 2004-04-22 Aventis Pasteur Limited Two-step immunization procedure against chlamydia infection
US7807802B2 (en) 2002-11-12 2010-10-05 Abbott Lab Polynucleotides for the amplification and detection of Chlamydia trachomatis and Neisseria gonorrhoeae

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995012411A1 (fr) * 1993-11-03 1995-05-11 Pfizer Inc. Vaccin et procede de traitement contre les infections a chlamydia
WO1998002546A2 (fr) * 1996-07-12 1998-01-22 University Of Manitoba VACCINATION A L'ADN CONTRE L'INFECTION DUE A $i(CHLAMYDIA)
AR009600A1 (es) * 1996-10-28 2000-04-26 Astrazeneca Ab Secuencia de acido nucleico y aminoacidos relacionados con helicobacter pylori y composiciones de vacuna de la misma.
KR20010032336A (ko) * 1997-11-21 2001-04-16 브랑디 빠스깔 클라미디아 뉴모니아 게놈 서열과 폴리펩티드, 이의 단편및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도

Also Published As

Publication number Publication date
WO2000006743A3 (fr) 2000-05-04
CA2336534A1 (fr) 2000-02-10
EP1108033A2 (fr) 2001-06-20
WO2000006743A2 (fr) 2000-02-10
AU4793499A (en) 2000-02-21
JP2002524035A (ja) 2002-08-06

Similar Documents

Publication Publication Date Title
US6403101B1 (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
US6403102B1 (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
AU753984B2 (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
US20020102270A1 (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
MXPA01001092A (es) Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos.
AU5297399A (en) (chlamydia) antigens and corresponding dna fragments and uses thereof
US20030170259A1 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
MXPA01001088A (es) Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos.
MXPA01001090A (es) Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos.
MXPA01001091A (es) Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos.
WO2000006739A2 (fr) Antigenes de chlamydia et fragments d'adn correspondants, et utilisations de ceux-ci
MXPA01001089A (es) Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos.
MXPA01004396A (en) Chlamydia
EP1144638A2 (fr) Antigenes de chlamydia et fragments d'adn correspondants, et utilisations de ceux-ci
AU4793299A (en) (chlamydia) antigens and corresponding dna fragments and uses thereof